These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38270350)

  • 21. Nanoparticle approaches against bacterial infections.
    Gao W; Thamphiwatana S; Angsantikul P; Zhang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):532-47. PubMed ID: 25044325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gold nanoparticles synthesised by flavonoid tricetin as a potential antibacterial nanomedicine to treat respiratory infections causing opportunistic bacterial pathogens.
    Alsamhary K; Al-Enazi N; Alshehri WA; Ameen F
    Microb Pathog; 2020 Feb; 139():103928. PubMed ID: 31843547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing Bacterial Infections and Biofilm Formation Using Nanoparticles and Nanostructured Antibacterial Surfaces.
    Mi G; Shi D; Wang M; Webster TJ
    Adv Healthc Mater; 2018 Jul; 7(13):e1800103. PubMed ID: 29790304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent Advances in the Control of Clinically Important Biofilms.
    Krukiewicz K; Kazek-Kęsik A; Brzychczy-Włoch M; Łos MJ; Ateba CN; Mehrbod P; Ghavami S; Shyntum DY
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coumarin: a novel player in microbial quorum sensing and biofilm formation inhibition.
    Reen FJ; Gutiérrez-Barranquero JA; Parages ML; O Gara F
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2063-2073. PubMed ID: 29392389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.
    Wu ZL; Zhao J; Xu R
    Int J Nanomedicine; 2020; 15():9587-9610. PubMed ID: 33293809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress and prospects of nanomaterials against resistant bacteria.
    He J; Hong M; Xie W; Chen Z; Chen D; Xie S
    J Control Release; 2022 Nov; 351():301-323. PubMed ID: 36165865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including Biofilms.
    Borges A; Abreu AC; Dias C; Saavedra MJ; Borges F; Simões M
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide-releasing compounds for the treatment of lung infections.
    Chiarelli LR; Degiacomi G; Egorova A; Makarov V; Pasca MR
    Drug Discov Today; 2021 Feb; 26(2):542-550. PubMed ID: 33181094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging nanoparticle designs against bacterial infections.
    Zhou Z; Kai M; Wang S; Wang D; Peng Y; Yu Y; Gao W; Zhang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1881. PubMed ID: 36828801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenge of treating biofilm-associated bacterial infections.
    del Pozo JL; Patel R
    Clin Pharmacol Ther; 2007 Aug; 82(2):204-9. PubMed ID: 17538551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic treatment of biofilm infections.
    Ciofu O; Rojo-Molinero E; Macià MD; Oliver A
    APMIS; 2017 Apr; 125(4):304-319. PubMed ID: 28407419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Are new antibiotics in therapy of respiratory tract infections necessary?].
    Haberl R; Wenisch C; Domej W
    Wien Med Wochenschr; 2003; 153(15-16):345-8. PubMed ID: 13677256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin Poly(β-amino ester) Conjugates Enhance Antibiofilm Activity and Slow the Development of Resistance.
    Kasza K; Richards B; Jones S; Romero M; Robertson SN; Hardie KR; Gurnani P; Cámara M; Alexander C
    ACS Appl Mater Interfaces; 2024 Feb; 16(5):5412-5425. PubMed ID: 38289032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Strategies to Combat Bacterial Biofilms.
    Hemmati F; Rezaee MA; Ebrahimzadeh S; Yousefi L; Nouri R; Kafil HS; Gholizadeh P
    Mol Biotechnol; 2021 Jul; 63(7):569-586. PubMed ID: 33914260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.
    Loo CY; Lee WH; Lauretani G; Scalia S; Cipolla D; Traini D; Young P; Ong HX
    Pharm Res; 2018 Feb; 35(3):50. PubMed ID: 29417313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.